Lymphoscintigraphy in Patients With Vaginal Cancer

Completed · Not applicable

Conditions studied: Vaginal Cancer

In brief

Primary Objectives: 1. Determine the feasibility of using pretreatment lymphoscintigraphy to identify the sentinel lymph node(s) in patients with vaginal cancer dispositioned to receive radiation therapy. 2. Determine the feasibility of using preoperative lymphoscintigraphy and intraoperative lymphatic mapping to identify the sentinel lymph node(s) in patients with vaginal cancer dispositioned to undergo surgery and bilateral lymph node dissection.

Key facts

Study ID

NCT00528034

Run by

M.D. Anderson Cancer Center

People needed

14

Starts

2002-09-01

Expected to finish

2008-05-01

Last updated by the study team

2012-08-01

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have invasive vaginal cancer, any histology, any stage.
• Patients with prior excision of the primary are eligible.
• Patients with recurrent vaginal cancer who have not had a prior inguinal or groin lymph node dissection.
• Patients undergoing either surgical resection and assessment of inguinal or groin lymph nodes, radiation therapy and/or chemotherapy.
• Patients must sign an IRB approved informed consent.

You may not qualify if…

• Known allergy to triphenylmethane compounds.
• Pregnancy.
• Prior radiation therapy to the vagina, vulva, groin or pelvis.
• Prior inguinal, femoral or pelvic lymphadenectomy.
• Patients who are not good surgical candidates.

Where it is running

• U.T.M.D. Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.